Medically reviewed by Dr. Ehtesham Ghani, Internal Medicine & Bariatric Medicine (ASBP). Last reviewed June 2026.
If you have been researching GLP-1 medications for weight loss, you have probably seen two very different versions advertised: brand-name semaglutide (sold as Wegovy and Ozempic) and “compounded” semaglutide offered at a lower cost by online pharmacies and clinics. They share the same active ingredient family, but they are not the same product, they are not regulated the same way, and the rules around compounding have tightened significantly since 2025. Here is an honest, physician-supervised comparison so you can make an informed decision with your ThinFast MD care team across our Hinsdale, Arlington Heights, Brookfield, and Rockford, Illinois locations.
What is brand-name semaglutide?
Brand-name semaglutide is an FDA-approved, mass-manufactured medication made by a single pharmaceutical company under strict federal oversight. Wegovy is FDA-approved specifically for chronic weight management, and Ozempic is FDA-approved for type 2 diabetes (sometimes prescribed off-label for weight by physicians). Because these are FDA-approved products, every batch is held to the agency’s manufacturing, potency, purity, and labeling standards. When used with diet, exercise, and medical supervision, semaglutide has been studied in large clinical trials; in the STEP 1 trial reported in the New England Journal of Medicine (Wilding et al., 2021), participants on the 2.4 mg dose lost on average in the range of roughly 15% of body weight (an estimated mean of about 14.9%) over 68 weeks, compared with about 2.4% on placebo. Individual results vary, and that figure comes from a controlled trial setting, not a guarantee. You can learn more on our GLP-1 / semaglutide and Wegovy / Ozempic pages.
What is compounded semaglutide?
Compounded semaglutide is prepared by a compounding pharmacy rather than the original drug manufacturer. Compounding is a long-standing, legitimate part of medicine: a licensed pharmacy customizes a medication for a specific patient who has a valid prescription. During the period when the FDA listed semaglutide as being in shortage, compounding pharmacies were permitted broader latitude to prepare it to help meet demand. That landscape has changed substantially. The FDA determined the semaglutide shortage was resolved on February 21, 2025, and the enforcement grace period for 503A pharmacies ended April 22, 2025 (May 22, 2025 for 503B outsourcing facilities). Once a drug is no longer in shortage, federal law generally prohibits compounding a product that is “essentially a copy” of a commercially available, FDA-approved drug. Importantly, compounded versions are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality the way brand-name semaglutide is.
Is compounded semaglutide legal in 2026?
The honest answer is that it is now much more restricted than it was during the shortage. Because the shortage is resolved, compounding a product that is “essentially a copy” of Wegovy or Ozempic is generally not permitted. There remain narrow circumstances in which a 503A pharmacy may compound a semaglutide-containing preparation for an individual patient with a valid prescription, for example when a physician documents a specific clinical need that the FDA-approved product does not meet. The wide-scale, telehealth-only compounding seen during the shortage is the activity the FDA has moved against, including a large coordinated enforcement wave in 2026. We want to be clear and not overstate certainty: federal and state guidance continues to evolve and can change. This is exactly why physician oversight matters. At ThinFast MD, any medication is prescribed only when it is clinically appropriate, sourced responsibly, and monitored over time.
How do compounded and brand-name semaglutide compare on safety and quality?
The core difference is oversight. Brand-name Wegovy and Ozempic carry FDA approval, standardized dosing, and manufacturer prescribing information you and your physician can rely on. Compounded preparations do not carry FDA approval, so potency and formulation can vary between pharmacies. The FDA has warned about dosing errors with compounded injectable semaglutide, including instructions in “units” that led some patients to administer many times their intended dose, and about products that used salt forms (such as semaglutide sodium or semaglutide acetate) that are different active ingredients than the form in approved drugs. None of this means compounding is inherently unsafe; it means the safeguards depend heavily on the quality of the pharmacy and the strength of the medical supervision behind the prescription. A reputable program verifies the pharmacy, confirms the formulation, teaches correct dosing, and follows you with regular visits.
What safety risks should I know before starting semaglutide?
This applies to both brand-name and compounded semaglutide. According to the FDA prescribing information, semaglutide carries a boxed warning: in rodent studies it caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC); whether this risk applies to humans has not been determined. Because of this, semaglutide is contraindicated in people with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The most common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, abdominal pain, and constipation, and serious reactions can occur. This is one more reason an in-person evaluation matters: your physician can review your personal and family history, screen for these contraindications, and decide whether semaglutide is appropriate for you. This page is educational and is not a substitute for that individualized assessment.
Why does in-person physician supervision matter more than the label?
Many mail-order and telehealth-only competitors ship semaglutide after a brief online questionnaire, with no physical exam and no lab work. That is the real risk, regardless of whether the drug is brand or compounded. ThinFast MD has practiced physician-supervised medical weight loss since 1984. Before prescribing any GLP-1, our team performs an in-person evaluation that can include a history and physical, baseline labs, an EKG when indicated, and a review of your metabolism and any conditions such as PCOS, type 2 diabetes or prediabetes, or thyroid and Hashimoto’s disease. This matters because semaglutide is a medical decision, not a retail purchase. With diet, exercise, and ongoing medical supervision, the medication becomes one tool inside a complete plan rather than a pill or pen mailed to your door.
Which option is right for you, and what about cost?
There is no single right answer for everyone. For most patients, FDA-approved Wegovy or Ozempic is the clear choice, especially when insurance helps cover it. In the narrow situations where a compounded option may be appropriate, it should be prescribed and supervised by a physician and used only when clinically indicated. The best path depends on your health history, your goals, what your insurance covers, and current availability. We do not quote specific prices online because pricing, insurance coverage, and the right medication are all reviewed individually at your consultation. The goal at our four Illinois clinics is the same either way: the safest effective plan for you, monitored over time.
Frequently asked questions
Is compounded semaglutide the same as Wegovy or Ozempic?
No. They involve the same active ingredient family, but Wegovy and Ozempic are FDA-approved, mass-manufactured products, while compounded semaglutide is prepared by a compounding pharmacy and is not FDA-approved or reviewed for safety, effectiveness, and quality.
Is compounded semaglutide still legal in 2026?
It is much more restricted now. Because the FDA resolved the semaglutide shortage in February 2025 (with 503A enforcement discretion ending April 22, 2025), compounding a product that is “essentially a copy” of Wegovy or Ozempic is generally not permitted, with only narrow exceptions for a documented individual clinical need. The rules continue to evolve, so physician supervision is important.
How much weight can I expect to lose on semaglutide?
In the STEP 1 trial reported in the New England Journal of Medicine, participants on the 2.4 mg dose lost on average roughly 15% of body weight over 68 weeks when used with diet and exercise. Individual results vary, and these figures come from a clinical trial, not a guarantee.
Who should not take semaglutide?
According to FDA labeling, semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Your physician will review your history and screen for these and other contraindications before prescribing.
Why choose an in-person clinic over a mail-order GLP-1 service?
An in-person clinic can perform a history and physical, labs, an EKG when indicated, and a metabolism review before prescribing, then monitor you over time. Many telehealth-only sellers ship medication after only a brief questionnaire, which removes those safeguards.
What does compounded or brand semaglutide cost at ThinFast MD?
Pricing, insurance coverage, and the right medication for you are reviewed individually at your consultation, so we do not quote prices online. Call (708) 485-4050 to schedule an evaluation at our Hinsdale, Arlington Heights, Brookfield, or Rockford location.
This page is for educational purposes only and is not medical advice. Semaglutide and other weight-loss medications are prescribed only when clinically appropriate after a medical evaluation and are intended to be used with diet, exercise, and ongoing medical supervision. Individual results vary. Regulations regarding compounded medications have tightened and continue to evolve. Please consult Dr. Ghani or another qualified clinician at ThinFast MD before starting, changing, or stopping any treatment.
Find your nearest ThinFast MD clinic
We serve patients across the Chicago suburbs and Rockford. Choose your nearest location — Hinsdale, Arlington Heights, Brookfield, or Rockford — or call (708) 485-4050 to book. See all service areas.
